+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Demineralized Bone Matrix Market by Product, Administration Mode, Application, End-Use - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5968400
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Demineralized Bone Matrix Market grew from USD 671.14 million in 2023 to USD 713.36 million in 2024. It is expected to continue growing at a CAGR of 6.54%, reaching USD 1.04 billion by 2030.

The demineralized bone matrix (DBM) market can be defined as the market for bone graft substitutes derived from processed allograft bone, where the mineral content is removed to retain the proteinaceous matrix and growth factors, primarily to aid bone regeneration. DBM has become essential in orthopedic, dental, and reconstructive surgeries due to its osteoinductive properties. The applications extend to bone repair and regeneration in cases like spinal fusions, bone defects, fractures, and dental procedures, targeting hospitals, specialty clinics, and research institutes as primary end-users. Significant growth influencers in this market include increased prevalence of orthopedic disorders, advancements in DBM processing technologies, and a rising geriatric population propelling surgical procedures. Furthermore, an increasing inclination towards minimally invasive surgeries strengthens market demand. However, a major limitation is the risk of disease transmission and variability in graft quality, alongside regulatory hurdles. Challenges also lie in high costs and stringent clinical trials requirements, which can impede market momentum.

Despite these challenges, lucrative opportunities exist, such as penetrating emerging economies with healthcare infrastructural development. Exploring innovative DBM formulations to enhance functionality and reduce variability can provide competitive advantages. Moreover, developing synthetic alternatives with comparable efficacy or combining DBM with growth factors for superior regenerative potential presents promising avenues. Collaborating with research institutes to drive novel discoveries could enhance product portfolios. To grab these opportunities, building strong partnerships with healthcare providers and investing in marketing strategies that educate clinicians on DBM benefits are essential. The nature of this market is highly competitive and dynamic as it continuously evolves with technological advancements and regulatory changes. Therefore, businesses need to focus on innovative product development, strategic collaborations, and navigating regulatory landscapes adeptly to capture and expand market share.

Understanding Market Dynamics in the Demineralized Bone Matrix Market

The Demineralized Bone Matrix Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing prevalence of bone injuries and adoption of orthopedic surgeries
    • Government investments promoting orthopedic research activities
  • Market Restraints
    • High cost and reimbursement limitations of demineralized bone matrix
  • Market Opportunities
    • Advancements in the demineralized bone matrix materials
    • Collaboration between stakeholders for supply of demineralized bone matrix
  • Market Challenges
    • Quality and consistency concerns of demineralized bone matrix

Exploring Porter’s Five Forces for the Demineralized Bone Matrix Market

Porter’s Five Forces framework further strengthens the insights of the Demineralized Bone Matrix Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Demineralized Bone Matrix Market

External macro-environmental factors deeply influence the performance of the Demineralized Bone Matrix Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Demineralized Bone Matrix Market

The Demineralized Bone Matrix Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Demineralized Bone Matrix Market

The Demineralized Bone Matrix Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Demineralized Bone Matrix Market

The Demineralized Bone Matrix Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Demineralized Bone Matrix Market, highlighting leading vendors and their innovative profiles. These include Advanced Biotech Products P Ltd, AlloSource, Arthrex, Inc., Bioventus LLC, Cerapedics.Inc., Curasan AG, Exactech, Inc., Geistlich Pharma AG, Globus Medical, HansBioMed., Institut Straumann AG, Integra LifeSciences Holdings Corporation, Johnson & Johnson Services, Inc., KLS Martin SE & Co. KG, Kuros Biosciences Ltd., Medtronic PLC, NovaBone by Halma PLC, Orthofix Medical Inc., Osteogenics Biomedical, RTI Surgical Holdings, Inc., SpineWave, Inc., Stryker Corporation, Synerheal, XTANT Medical, and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Demineralized Bone Matrix Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Gel
    • Putty
    • Putty Combined with Cancellous Chips
  • Administration Mode
    • Implantation
    • Injection
  • Application
    • Craniomaxillofacial Surgeries
    • Dental Reconstructions
    • Joint Reconstruction
    • Orthopedic Repairs
    • Spinal Fusion Surgery
  • End-Use
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of bone injuries and adoption of orthopedic surgeries
5.1.1.2. Government investments promoting orthopedic research activities
5.1.2. Restraints
5.1.2.1. High cost and reimbursement limitations of demineralized bone matrix
5.1.3. Opportunities
5.1.3.1. Advancements in the demineralized bone matrix materials
5.1.3.2. Collaboration between stakeholders for supply of demineralized bone matrix
5.1.4. Challenges
5.1.4.1. Quality and consistency concerns of demineralized bone matrix
5.2. Market Segmentation Analysis
5.2.1. Product: Adoption of putty combined with cancellous chips form of DBM for extensive bone repair situations
5.2.2. Application: Exponential adoption of DBM for orthopedic surgical procedures
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Demineralized Bone Matrix Market, by Product
6.1. Introduction
6.2. Gel
6.3. Putty
6.4. Putty Combined with Cancellous Chips
7. Demineralized Bone Matrix Market, by Administration Mode
7.1. Introduction
7.2. Implantation
7.3. Injection
8. Demineralized Bone Matrix Market, by Application
8.1. Introduction
8.2. Craniomaxillofacial Surgeries
8.3. Dental Reconstructions
8.4. Joint Reconstruction
8.5. Orthopedic Repairs
8.6. Spinal Fusion Surgery
9. Demineralized Bone Matrix Market, by End-Use
9.1. Introduction
9.2. Hospitals
9.3. Specialty Clinics
10. Americas Demineralized Bone Matrix Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Demineralized Bone Matrix Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Demineralized Bone Matrix Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Paragon 28 Launches BEAST Cortical Fibers Expanding its Biologics Portfolio
13.3.2. Biogennix Launches OsteoSPAN Fiber Matrix
13.3.3. Geistlich Announces The Dramatic Expansion Of Their Allograft Portfolio
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. DEMINERALIZED BONE MATRIX MARKET RESEARCH PROCESS
FIGURE 2. DEMINERALIZED BONE MATRIX MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 13. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. DEMINERALIZED BONE MATRIX MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. DEMINERALIZED BONE MATRIX MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DEMINERALIZED BONE MATRIX MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. DEMINERALIZED BONE MATRIX MARKET DYNAMICS
TABLE 7. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY COMBINED WITH CANCELLOUS CHIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY IMPLANTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY DENTAL RECONSTRUCTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ORTHOPEDIC REPAIRS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY SPINAL FUSION SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 36. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 38. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 40. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 42. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 58. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 60. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 62. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 64. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 70. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 72. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 94. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 96. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 107. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 109. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 111. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 113. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 115. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 117. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 119. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 121. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 123. GERMANY DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. GERMANY DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 125. GERMANY DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. GERMANY DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 131. ITALY DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. ITALY DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 133. ITALY DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. ITALY DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 143. NORWAY DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. NORWAY DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 145. NORWAY DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. NORWAY DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 147. POLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. POLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 149. POLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. POLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 151. QATAR DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 152. QATAR DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 153. QATAR DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. QATAR DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 167. SPAIN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. SPAIN DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 169. SPAIN DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. SPAIN DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 179. TURKEY DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. TURKEY DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 181. TURKEY DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. TURKEY DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 191. DEMINERALIZED BONE MATRIX MARKET SHARE, BY KEY PLAYER, 2023
TABLE 192. DEMINERALIZED BONE MATRIX MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Demineralized Bone Matrix Market, which are profiled in this report, include:
  • Advanced Biotech Products P Ltd
  • AlloSource
  • Arthrex, Inc.
  • Bioventus LLC
  • Cerapedics.Inc.
  • Curasan AG
  • Exactech, Inc.
  • Geistlich Pharma AG
  • Globus Medical
  • HansBioMed.
  • Institut Straumann AG
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • KLS Martin SE & Co. KG
  • Kuros Biosciences Ltd.
  • Medtronic PLC
  • NovaBone by Halma PLC
  • Orthofix Medical Inc.
  • Osteogenics Biomedical
  • RTI Surgical Holdings, Inc.
  • SpineWave, Inc.
  • Stryker Corporation
  • Synerheal
  • XTANT Medical
  • Zimmer Biomet

Methodology

Loading
LOADING...

Table Information